Quantification of frequent-hitter behavior based on historical high-throughput screening data

被引:0
|
作者
Nissink, J. Willem M. [1 ]
Blackburn, Sam [2 ]
机构
[1] AstraZeneca, Oncol Innovat Med, Macclesfield SK10 4TG, Cheshire, England
[2] AstraZeneca, Discovery Sci, Macclesfield SK10 4TG, Cheshire, England
关键词
INHIBITORS; ASSAY; AGGREGATION; SORAFENIB; DISCOVERY; RHODANINE; PAINS;
D O I
10.4155/FMC.14.72
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aim: We mine historical high-throughput data to identify and characterize 'frequent hitters', hits that are potentially false-positive results. Background: A key problem in the field of high-throughput screening (HTS) is recognition of frequent hitters, which are false-positive or otherwise anomalous compounds that tend to crop up across many screens. Follow-up of such compounds constitutes a waste of resource and decreases efficiency. Methodology: We describe a systematic retrospective approach to identify anomalous hitter behavior using historical screening data. We take into account the uncertainty that arises if not enough screen data are available and extend implementation to target and technology classes. Conclusion: Use of the descriptor in analyzing high-throughput screen results frees up resource for follow-up of more likely true hits in the downstream hit-deconvolution cascade, thereby increasing efficiency of screen delivery. Although effective, historical data bias can affect the annotation, and we exemplify cases where this happened.
引用
收藏
页码:1113 / 1126
页数:14
相关论文
共 50 条
  • [21] High-throughput quantification of early stages of phagocytosis
    Yeo, Jeremy Changyu
    Wall, Adam Alexander
    Stow, Jennifer Lea
    Hamilton, Nicholas Ahti
    BIOTECHNIQUES, 2013, 55 (03) : 115 - +
  • [22] High-throughput corrosion quantification in varied microenvironments
    Whitfield, Matthew J.
    Bono, David
    Wei, Lei
    Van Vliet, Krystyn J.
    CORROSION SCIENCE, 2014, 88 : 481 - 486
  • [23] Stratified High-Throughput Screening Sets Enable Flexible Screening Strategies from a Single Plated Collection
    Nissink, J. Willem M.
    Schmitt, Stefan
    Blackburn, Sam
    Peters, Stephen
    JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (03) : 369 - 378
  • [24] Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds
    Alves, Vinicius M.
    Yasgar, Adam
    Wellnitz, James
    Rai, Ganesha
    Rath, Marielle
    Braga, Rodolpho C.
    Capuzzi, Stephen J.
    Simeonov, Anton
    Muratov, Eugene N.
    Zakharov, Alexey V.
    Tropsha, Alexander
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (18) : 12828 - 12839
  • [25] GUItars: A GUI Tool for Analysis of High-Throughput RNA Interference Screening Data
    Goktug, Asli N.
    Ong, Su Sien
    Chen, Taosheng
    PLOS ONE, 2012, 7 (11):
  • [26] Cell-Based Screening Using High-Throughput Flow Cytometry
    Black, Christopher B.
    Duensing, Thomas D.
    Trinkle, Linda S.
    Dunlay, R. Terry
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2011, 9 (01) : 13 - 20
  • [27] High-Throughput Screening of a Diversity Collection Using Biodefense Category A and B Priority Pathogens
    Barrow, Esther W.
    Clinkenbeard, Patricia A.
    Duncan-Decocq, Rebecca A.
    Perteet, Rachel F.
    Hill, Kimberly D.
    Bourne, Philip C.
    Valderas, Michelle W.
    Bourne, Christina R.
    Clarkson, Nicole L.
    Clinkenbeard, Kenneth D.
    Barrow, William W.
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (07) : 946 - 956
  • [28] High-throughput screening technologies for enzyme engineering
    Longwell, Chelsea K.
    Labanieh, Louai
    Cochran, Jennifer R.
    CURRENT OPINION IN BIOTECHNOLOGY, 2017, 48 : 196 - 202
  • [29] High-throughput screening of nanoparticles in drug delivery
    Tome, Ines
    Francisco, Vitor
    Fernandes, Hugo
    Ferreira, Lino
    APL BIOENGINEERING, 2021, 5 (03)
  • [30] HTRF®: pioneering technology for high-throughput screening
    Degorce, Francois
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (07) : 753 - 764